SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is currently surging as investors recalibrate their valuation of the stock, shifting from viewing it as a cyclical commodity play to a critical piece of permanent AI infrastructure. Community members are actively debating the sustainability of this parabolic move, with many bulls emphasizing structural memory shortages and forward earnings metrics while cautious bears highlight potential overextension and macroeconomic risks.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing intense community polarization as investors debate whether the current price action represents a healthy consolidation before a major breakout or a vulnerable position prone to further downside. While bulls point to technical chart patterns and long-term optimism, others are actively betting on a correction, fueling a volatile environment of intense speculation and aggressive sentiment in the trenches.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently surging following a robust earnings report that showcased record revenue and a significantly expanded backlog, signaling to investors that the company is transitioning from a speculative launch play into a scaled space infrastructure provider. The community is heavily focused on the stock's massive volume and upward momentum, with many drawing parallels to other high-growth tech names and speculating on further gains ahead of potential sector-wide catalysts like the highly anticipated SpaceX IPO.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending as investors rally behind anticipation for a pivotal conference call to discuss interim glioblastoma data. The community is actively discussing the company's strong clinical pipeline, with many participants expressing significant bullish sentiment and highlighting the stock's potential for growth.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is seeing significant volatility as it clears resistance, drawing intense attention from traders debating whether to book profits on recent gains or accumulate during the dip. The community remains heavily divided between long-term holders eyeing institutional potential and those reacting to the rapid price fluctuations and short-term liquidity shifts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors and institutions react to reports that FDA Commissioner Marty Makary may be ousted, potentially easing the path for the company's long-awaited sBLA approvals. Community discussion is heavily focused on the stock's elevated short interest and the strategic global expansion of Anktiva, with supporters rallying around the company's prospects following high-profile institutional accumulation.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The community is actively rallying around a meme coin associated with the MULN ticker, driven by speculative excitement, high-volatility trading, and efforts to boost its social media ranking. While supporters use aggressive hashtags and 'send it' calls to encourage accumulation, critics warn of potential risks by highlighting the company's past volatility and urging caution against what they categorize as a speculative pump-and-dump scheme.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending as investors capitalize on the company's strategic positioning within the AI and co-packaged optics supply chain, fueled by recent positive guidance and hardware partnerships. The community remains highly focused on the company's evolving role in high-growth segments like automotive display ICs and edge AI sensing while debating the sustainability of its recent market expansion.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive FDA pre-BLA meeting and strong support for its sonelokimab program, which the community sees as a potential best-in-class treatment for inflammatory skin diseases. Investors are actively debating the potential for an imminent buyout or significant price re-rating, with many closely watching upcoming 52-week clinical trial data and potential institutional accumulation.

Osmosis (OSMO) is the premier DEX and cross-chain DeFi hub within the Cosmos ecosystem, a network of over 50 sovereign, interoperable blockchains seamlessly connected through the Inter-Blockchain Communication Protocol (IBC). Pioneering in its approach, Osmosis offers a dynamic trading and liquidity provision experience, integrating non-IBC assets from other ecosystems, including Ethereum, Solana, Avalanche, and Polkadot. Initially adopting Balancer-style pools, Osmosis now also features a concentrated liquidity model that is orders of magnitude more capital efficient, meaning that significantly less liquidity is required to handle the same amount of trading volume with minimal slippage.

Osmosis

Osmosis is generating community discussion as traders monitor its price action and explore ecosystem developments like the Shido network integration. Investors remain focused on the potential for long-term growth and passive income opportunities through staking, despite broader market volatility impacting the DeFi sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TRNX 

I am so d__n tired of naysayers saying TRNF posts are this or that and YOU (me) should not be posting about TRNF because TRNF is on the OTC! 

TRNF is a Subsidary of TRNX and TRNF pays a 7% royalty to TRNX! 

Plus, TRNF will be up-listed to the NYSE after Labor Day! 

Go to their websites and read all about if &gt; if you naysaying bashing BS bears can read &gt; OK? 

https://www.taronistech.com/

https://taronisfuels.com/

Bryce

Cmon Man

Truth Speaks

Stocks Hero

Derrick G Hughes

Taronis Technologies, Inc. owns a patented plasma arc technology that enables two end-use applications for fuel generation and water decontamination.

Taronis Technologies, Inc.

Smarter Technology Solutions Providing renewable solutions for global fuel and water constraints. Taronis Fuels' technology enables a wide use of hydrocarbon-based renewable feedstocks to be readily converted to fossil fuel substitutes. Venturi Plasma Arc Technology Our patented plasma arc technology that enables

Taronis Fuels

Home

StockTwits Web

Taronis Technologies Inc

 

I am so d__n tired of naysayers saying TRNF posts are this or that and YOU (me) should not be posting about TRNF because TRNF is on the OTC! 

TRNF is a Subsidary of TRNX and TRNF pays a 7% royalty to TRNX! 

Plus, TRNF will be up-listed to the NYSE after Labor Day! 

Go to their websites and read all about if > if you naysaying bashing BS bears can read > OK? 



Willbe Payne

@Pro_kart 
Agree 100%

TRNX makes 7% Royalties off TRFN

Anything we make Royalties 7% cash with no labor or material, 
You darn right we cheer TRFN on!!!

 
Agree 100%

TRNX makes 7% Royalties off TRFN

Anything we make Royalties 7% cash with no labor or material, 
You darn right we cheer TRFN on!!!